International Journal of Clinical Science and Medical Research

Background: - One of the main causes of death worldwide is heart disease. Nearly 25% of cardiac patients experience non-fatal myocardial infractions or unexpected fatalities without any warning signs. Therefore, silent heart attacks are also known as silent myocardial infractions (SMI), and they might be entirely asymptomatic or have symptoms that are so subtle that patients are unable to recognize them. Even so, the ECG may not always be able to identify the symptoms. However,the signs of a traditional heart attack include cold chills, sobs, and chest pain. Despite their understated appearance, they pose serious long-term health hazards and harm the heart to the same extent. We believed that the fundamental processes of SMI involved a reduction or obstruction in the heart’s blood flow, upon forming plaques.The following patient groups are subjected here like Hypertension and hyper lipidaemia, diabetic, elderly, women, and smoking, Increased awareness regularly screening and preventive measures are essential to mitigate the silent threat by these unrecognised heart attacks. Hence, this study explores a complete prevalence, Risk factors and outcomes of silent heart attacks across different patient groups.

SMI – Silent Myocardial Infraction, HTN – Hypertension, SOB – shortness of breath, CVD – cardio vascular diseases, DM- Diabetes mellitus, CAD – Coronary artery disease.

1. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med. 1993 Dec 15;119(12):1187-97.
2. Nakamura S, Uzu T, Inenaga T, Kimura G. Prediction of coronary artery disease and cardiac events using electrocardiographic changes during hemodialysis. Am J Kidney Dis. 2000 Sep;36(3):592-9.
3. Aronow WS. Silent MI. Prevalence and prognosis in older patients diagnosed by routine electrocardiograms. Geriatrics. 2003 Jan;58(1):24-6, 36-8, 40.
4. Deanfield JE, Shea M, Ribiero P, de Landsheere CM, Wilson RA, Horlock P, Selwyn AP. Transient ST-segment depression as a marker of myocardial ischemia during daily life. Am J Cardiol. 1984 Dec 1;54(10):1195-200.
5. Huffman MD, Berry JD, Ning H, Dyer AR, Garside DB, Cai X, Daviglus ML, Lloyd-Jones DM. Lifetime risk for heart failure among white and black Americans: cardiovascular lifetime risk pooling project. J Am Coll Cardiol. 2013 Apr 9;61(14):1510-7.
6. Silent myocardial ischemia ; diagnosis , treatment and prognosis, consultant 360.2011( cited 2023 oct 31)
7. Njølstad I, Arnesen E. Preinfarction blood pressure and smoking are determinants for a fatal outcome of myocardial infarction: a prospective analysis from the Finnmark Study. Arch Intern Med. 1998 Jun 22;158(12):1326-32.
8. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV. Detection of Ischemia in Asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004 Aug;27(8):1954-61.
9. FlegJL, Gerstenblith G, Zonderman AB, Becker LC, Weisfeldt ML, Costa PT Jr, prevalence and prognostic significance of exercise induced silent myocardial ischekia.1990;81(2) ;428-436
10. Wenger NK. Women and coronary heart disease: a century after Herrick: understudied, underdiagnosed, and undertreated. Circulation. 2012 Jul 31;126(5):604-11.
11. Qureshi WT, Zhang ZM, Chang PP, Rosamond WD, Kitzman DW, Wagenknecht LE, Soliman EZ. Silent MyocardialInfarction and Long-Term Risk ofHeart Failure: The ARIC Study. J Am Coll Cardiol. 2018 Jan 2;71(1):1-8.
12. Ruidavents J. Ducimetière P, Evans A, Montaye M, Haas B, Bingham A, pattern of alcohol consumption on ischemic heart diseases in culturally divergent countries; A prospective epidemiological study of MI 2010 .341( v 231).